Tuberculosis in Mexico: Now the Second Most Common Infectious Disease

Mexico is facing a growing public health challenge: tuberculosis (TB) has become the second most frequent infectious disease in the country. This resurgence, occurring even as global efforts aim to eliminate TB, underscores the demand for increased awareness, early detection, and accessible treatment. The World Health Organization (WHO) and Pan American Health Organization (PAHO) are emphasizing the critical role of primary healthcare in addressing this escalating situation.

A Historical Perspective on TB Discovery

The commemoration of World Tuberculosis Day on March 24th marks a pivotal moment in medical history. In 1882, Dr. Robert Koch announced his discovery of the bacterium, Mycobacterium tuberculosis, the causative agent of TB. This breakthrough paved the way for diagnostic tools and, treatments for a disease that had long plagued humanity. However, despite these advances, TB remains a significant global health threat, and its incidence is, unfortunately, rising in some regions, including Mexico.

The Importance of Primary Healthcare

Effective TB control hinges on a robust primary healthcare system. The PAHO highlights that primary care professionals are essential for early detection through routine screening, prompt diagnosis, and consistent monitoring of treatment adherence. This approach ensures that care is delivered closer to communities, making it more accessible and patient-centered. The focus on primary care is particularly important for vulnerable populations who may face barriers to accessing specialized medical facilities.

New WHO guidelines are aiming to improve access to rapid TB testing, particularly at the primary care level. These portable, easy-to-employ tests can provide results in under an hour, allowing for quicker treatment initiation. Crucially, these tests are available at a lower cost than many existing molecular diagnostic methods, potentially expanding access in resource-limited settings. WHO’s World TB Day campaign emphasizes that ending TB is possible with commitment, investment, and action.

Understanding the Symptoms and Transmission

Tuberculosis primarily affects the lungs, but it can similarly impact other parts of the body. Common symptoms include a persistent cough lasting three weeks or more, often accompanied by phlegm or blood, chest pain, fever, night sweats, unexplained weight loss, and fatigue. It’s important to note that these symptoms can also be indicative of other conditions, so a proper diagnosis is crucial.

TB is spread through the air when a person with active TB disease coughs, speaks, sings, or sneezes. People with latent TB infection are not infectious and do not experience symptoms, but they can develop active TB disease if their immune system weakens. Early detection and treatment of both active TB disease and latent TB infection are vital to prevent further transmission.

New Diagnostic Tools and Innovations

The WHO is encouraging countries to adopt innovative diagnostic tools, such as tongue swab samples, which can help detect the disease more rapidly and reach more people. These advancements are particularly important in areas where access to traditional sputum collection methods may be limited. The ability to quickly and accurately diagnose TB is a game-changer in controlling the epidemic.

These new guidelines also recommend using tongue swabs to collect samples, a simpler and more cost-effective method for grouping sputum samples. This increases the efficiency of TB and drug-resistant TB screening. The WHO Director-General, Tedros Adhanom, emphasized that these tools could be “truly transformative” for TB control, bringing faster and more accurate diagnoses to those who need them, saving lives, and slowing transmission. PAHO’s information on World Tuberculosis Day details these advancements.

Global Progress and Ongoing Challenges

Significant progress has been made in the global fight against TB. Since 2000, global efforts have saved an estimated 83 million lives. However, recent cuts in global health funding pose a threat to these gains. The adoption of rapid diagnostic tools has been hampered by high costs and the need for centralized laboratory testing in many countries.

Each day, over 3,300 people die from TB, and nearly 29,000 contract this preventable and curable disease. The emergence of multidrug-resistant TB further complicates the situation, posing a serious threat to public health. Mexico’s national health institute (INSABI) acknowledges the serious social, economic, and health consequences of TB.

What Comes Next: A Call to Action

The WHO is urging all countries to expand access to these new tools and other resources to ensure that everyone with TB receives prompt and effective care. This includes strengthening primary healthcare systems, increasing investment in research and development, and addressing the social and economic factors that contribute to TB transmission. Continued surveillance and monitoring of TB incidence and drug resistance patterns are also crucial for guiding public health interventions. The focus must remain on a comprehensive, collaborative approach to eliminate TB as a public health threat.